FNY Investment Advisers, LLC

Position in FRNM — Freenome, Inc.

CIK 1742998 NEW YORK, NY

Position in FRNM

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$1,745,859

+$1,028,751 QoQ

Shares Held

160,465

+145.5% QoQ

Ownership

1.56%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

of 1 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $3,072,180 across 5 Diagnostics & Research names. FRNM ranks #1 (56.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FRNM	Freenome, Inc. This page	160,465	$1,745,859
2	IMDX	Insight Molecular Diagnostics Inc.	182,561	$1,077,109
3	ILMN	Illumina, Inc.	650	$114,289
4	TMO	Thermo Fisher Scientific Inc.	150	$75,204
5	NTRA	Natera, Inc.	220	$59,719

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,745,859	160,465	+145.5%	Shares	Sole	2026-07-08
2026-03-31	$717,108	65,370	+30.8%	Shares	Sole	2026-04-15
2025-12-31	$651,017	49,963	-54.7%	Shares	Sole	2026-01-16
2025-09-30	$1,169,392	110,320	+0.0%	Shares	Sole	2025-12-15
2025-06-30	$1,171,173	110,280	+0.2%	Shares	Sole	2025-07-30
2025-03-31	$1,134,133	110,110	+10.1%	Shares	Sole	2025-04-17
2024-12-31	$1,018,000	100,000	+233.3%	Shares	Sole	2025-01-13
2024-09-30	$300,600	30,000	+200.0%	Shares	Sole	2024-10-18
2024-06-30	$100,600	10,000	—	Shares	Sole	2024-08-05
No filing history on record for this holder in this stock.